TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / SmithRx Stock

SmithRx Stock

www.smithrx.comHealthcare / Digital HealthFounded: 2016

With a focus on finding a better way to manage employee pharmacy benefits, SmithRx is a pharmacy benefit management (PBM) company that aims to use technology to connect employers and health plan members to specialized programs for pharmaceutical coverage. It provides a platform for small businesses so they can gain transparency and alternative methods to deliver pharmacy benefits. As a result, SmithRX strives to enable employees to access medications that are affordable and easy to acquire while also trying to reduce overhead costs for employers. SmithRx was was founded by Jake Frenz in 2016 and is headquartered in San Francisco, CA.

Buy or sell SmithRx stockLearn more about SmithRx IPO

Register To Buy and Sell Shares

For more details on financing and valuation for SmithRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access SmithRx’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like SmithRx.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

SmithRx investors also invested in these private companies

Venrock
BoxGroup
Founders Fund
Great Oaks Venture Capital
Blumberg Capital
Catapult VC
FourCities Capital
NextGen Venture Partners
Metaplanet Holdings
SciFi VC
Precursor Ventures
Presight Capital
MCVC Partners
W Ventures
Highbury Group

Team

Management Team

Jacob Frenz
Founder & Chief Executive Officer

Board Members

Bryan Roberts Ph.D
Venrock

Frequently Asked Questions About SmithRx’s Stock

plusminus
Can you buy SmithRx’s stock?
SmithRx is not publicly traded on NYSE or NASDAQ in the U.S. To buy SmithRx’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell SmithRx’s stock?
Yes, you can sell stock of a private company like SmithRx. Forge can help you sell your SmithRx stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is SmithRx’s stock price?
SmithRx is a privately held company and therefore does not have a public stock price. However, you may access SmithRx’s private market stock price with Forge Data.
plusminus
What is SmithRx’s stock ticker symbol?
SmithRx does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like SmithRx in the Digital Health sector

OURA

Sector
Healthcare / Digital Health
 
 

Brightline

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$705.25MM

ZocDoc

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$2.62B

Hinge Health

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$6.2B

Ro

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$7.19B

Calm

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$404.67MM

Maven

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$1.35B

Included Health

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$1.13B

PathAI

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$1.11B

News Highlights

Business Wire 01/23/2024
SmithRx Continues to Fix Broken Pharmacy Benefits Management System, Closes $60M in Series C Funding Led by Venrock
SmithRx, a next-generation pharmacy benefits management (PBM) company, closed a $60M Series C financing round — building on the company’s $20M Series B round raised in 2022. Led by top Silicon Valley healthcare venture capital firm Venrock, the latest funding positions SmithRx to continue reducing costs of pharmacy benefits for small and midsize self-insured businesses.

Trending Companies

Frequently Asked Questions

Updated on: Apr 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.